Literature DB >> 10550295

Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.

L L Siu1, K F Wong, J K Chan, Y L Kwong.   

Abstract

Putative natural killer (NK) cell lymphoma/leukemia is a rare group of recently characterized hematolymphoid malignancies. They are highly aggressive and frequently present in extranodal sites, including the nasal area and the upper aerodigestive system, and nonnasal areas such as the skin and the gastrointestinal tract. According to clinicopathological features, they can be classified into nasal NK cell lymphoma, nasal-type NK cell lymphoma occurring in nonnasal areas, and NK cell lymphoma/leukemia. Genetic alterations in NK cell lymphoma/leukemia are not well defined. In this study, we have performed comparative genomic hybridization (CGH) on DNA extracted from fresh or frozen tissues of 10 patients with NK cell lymphoma/leukemia. They comprised four nasal NK cell lymphomas, one nasal-type NK cell lymphoma, and five NK cell lymphomas/leukemias. CGH showed frequent deletions at 6q16-q27 (four cases), 13q14-q34 (three cases), 11q22-q25 (two cases), 17p13 (two cases), and loss of the whole chromosome X (two cases). DNA amplification was observed in a majority of the chromosomes. Five cases showed DNA gains at region 1p32-pter. Frequent DNA gains were also found in chromosomes 6p, 11q, 12q, 17q, 19p, 20q, and Xp (three cases each). Interestingly, DNA gains were more frequent in nasal/nasal-type NK cell lymphomas than NK cell lymphoma/leukemia. These genetic alterations correlated well with karyotypic features found in some of the cases. The frequent DNA losses at 6q and 13q suggest that the presence of tumor suppressor genes at these regions is important in NK cell transformation. In addition to establishing novel patterns of genomic imbalances in these rare NK cell malignancies, which may be targets for future molecular analysis, this study also provides important information on genetic alterations in NK cell lymphomas that may be useful in defining their positions in current lymphoma classification schemes, which are increasingly focusing on phenotypic and genotypic correlations.

Entities:  

Mesh:

Year:  1999        PMID: 10550295      PMCID: PMC1866965          DOI: 10.1016/S0002-9440(10)65454-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  CD56+ NK lymphomas: clinicopathological features and prognosis.

Authors:  Y L Kwong; A C Chan; R Liang; A K Chiang; C S Chim; T K Chan; D Todd; F C Ho
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

2.  6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma.

Authors:  K Offit; N Z Parsa; G Gaidano; D A Filippa; D Louie; D Pan; S C Jhanwar; R Dalla-Favera; R S Chaganti
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

Review 3.  Comparative genomic hybridization: an overview.

Authors:  J Houldsworth; R S Chaganti
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

4.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Authors:  A Kallioniemi; O P Kallioniemi; D Sudar; D Rutovitz; J W Gray; F Waldman; D Pinkel
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

5.  Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

Authors:  J Isola; S DeVries; L Chu; S Ghazvini; F Waldman
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

6.  Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement.

Authors:  W F Kern; C M Spier; E H Hanneman; T P Miller; M Matzner; T M Grogan
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

7.  Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification.

Authors:  M R Speicher; S du Manoir; E Schröck; H Holtgreve-Grez; B Schoell; C Lengauer; T Cremer; T Ried
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

Review 8.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

Review 9.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

Authors:  O P Kallioniemi; A Kallioniemi; J Piper; J Isola; F M Waldman; J W Gray; D Pinkel
Journal:  Genes Chromosomes Cancer       Date:  1994-08       Impact factor: 5.006

10.  In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.

Authors:  W Y Tsang; J K Chan; T T Yip; C S Ng; K F Wong; Y F Poon; V W Ma
Journal:  Hum Pathol       Date:  1994-08       Impact factor: 3.466

View more
  31 in total

1.  Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.

Authors:  Andreas Zettl; Thomas Rüdiger; Maria-Anette Konrad; Andreas Chott; Ingrid Simonitsch-Klupp; Ruth Sonnen; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

2.  PRDM1 is a tumor suppressor gene in natural killer cell malignancies.

Authors:  Can Küçük; Javeed Iqbal; Xiaozhou Hu; Phillip Gaulard; Laurence De Leval; Gopesh Srivastava; Wing Yan Au; Timothy W McKeithan; Wing C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature.

Authors:  John Ryder; Xiaoqin Wang; Liming Bao; Sherilyn A Gross; Fu Hua; Richard D Irons
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

Review 4.  Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

Authors:  Bradley M Haverkos; Carrie Coleman; Alejandro A Gru; Zenggang Pan; Jonathan Brammer; Rosemary Rochford; Anjali Mishra; Christopher C Oakes; Robert A Baiocchi; Aharon G Freud; Pierluigi Porcu
Journal:  Discov Med       Date:  2017-03       Impact factor: 2.970

5.  Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma.

Authors:  Andreas Zettl; German Ott; Angela Makulik; Tiemo Katzenberger; Petr Starostik; Thorsten Eichler; Bernhard Puppe; Martin Bentz; Hans Konrad Müller-Hermelink; Andreas Chott
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Consistent patterns of allelic loss in natural killer cell lymphoma.

Authors:  L L Siu; V Chan; J K Chan; K F Wong; R Liang; Y L Kwong
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 7.  NK cell lymphoma.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

8.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yenlin Huang; Aurélien de Reyniès; Laurence de Leval; Bouchra Ghazi; Nadine Martin-Garcia; Marion Travert; Jacques Bosq; Josette Brière; Barbara Petit; Emilie Thomas; Paul Coppo; Teresa Marafioti; Jean-François Emile; Marie-Hélène Delfau-Larue; Christian Schmitt; Philippe Gaulard
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

Review 9.  Leukemia and lymphoma of natural killer lineage cells.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 10.  Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Authors:  Keisei Kawa
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.